See the DrugPatentWatch profile for myrbetriq
Information regarding which specific insurance plans cover Myrbetriq is not available in the provided text.
What is Myrbetriq used for?
Myrbetriq (mirabegron) is a medication prescribed to treat overactive bladder (OAB) with or without urinary incontinence, urgency, and urinary frequency [1]. It works by relaxing the bladder muscle, which helps to increase bladder capacity [1].
How does Myrbetriq work?
Myrbetriq is a beta-3 adrenergic agonist. It activates beta-3 adrenergic receptors in the bladder's detrusor muscle, leading to smooth muscle relaxation. This relaxation increases the bladder's ability to store urine, thereby reducing the symptoms of overactive bladder such as urgency, frequency, and incontinence [1].
What are the potential side effects of Myrbetriq?
Common side effects of Myrbetriq include high blood pressure, urinary tract infection, headache, and constipation [1].
When does Myrbetriq's patent expire?
The patent expiration date for Myrbetriq is not provided in the available information. DrugPatentWatch.com tracks patent information for pharmaceuticals [2].
Can generic versions of Myrbetriq be made?
The availability of generic versions of Myrbetriq depends on patent expirations and regulatory approvals. Information on generic availability or the timeline for its potential release is not present.
---
Sources:
[1] https://www.myrbetriq.com/
[2] https://www.drugpatentwatch.com/